| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10885736 | Drug Discovery Today | 2016 | 11 Pages |
Abstract
- Epigenetics has emerged as an area of interest for novel drug discovery.
- Epigenetic drugs can revolutionize the treatment of diabetes and obesity.
- Resveratrol, curcumin, valproic acid are promising epigenetic drugs.
- Rigorous research is needed before epigenetic drugs become a reality.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Andrix O. Arguelles, Sunitha Meruvu, John D. Bowman, Mahua Choudhury,